bladder carcinoma
calcium intake measurement, colorectal cancer
cancer aggressiveness measurement, Gleason score measurement, prostate carcinoma
colorectal adenoma
colorectal cancer
colorectal cancer, alcohol consumption measurement
colorectal cancer, breast carcinoma
colorectal cancer, colorectal mucinous adenocarcinoma
colorectal cancer, diet measurement
colorectal cancer, endometrial neoplasm
colorectal cancer, hormone replacement therapy
colorectal cancer, microsatellite instability measurement
colorectal cancer, microsatellite instability measurement, overall survival
colorectal cancer, sclerosing cholangitis
colorectal cancer, skin disease, response to cetuximab
colorectal cancer, survival time
differentiated thyroid carcinoma
disease free survival, colorectal cancer, microsatellite instability measurement
disease free survival, rectum cancer
drug use measurement, aspirin use measurement, NSAID use measurement, colorectal cancer
esophageal adenocarcinoma
esophageal adenocarcinoma, Barrett's esophagus
esophageal adenocarcinoma, digestive system disease, Barrett's esophagus
esophageal adenocarcinoma, gastroesophageal reflux disease
esophageal adenocarcinoma, pack-years measurement
esophageal adenocarcinoma, smoking status measurement
esophageal carcinoma
esophageal squamous cell carcinoma
event free survival time, non-small cell lung carcinoma
gastric adenocarcinoma
gastric carcinoma
gastric cardia carcinoma
hepatocellular carcinoma
hepatocellular carcinoma, hepatitis B infection
hepatocellular carcinoma, hepatitis C infection
hepatocellular carcinoma, non-alcoholic steatohepatitis
longitudinal BMI measurement, Digestive System Carcinoma
longitudinal BMI measurement, Digestive System Carcinoma, chronic obstructive pulmonary disease
lung adenocarcinoma
lung adenocarcinoma, family history of lung cancer
lung carcinoma
lung carcinoma, asbestos exposure measurement
lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma
lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma
lung carcinoma, family history of lung cancer
lung carcinoma, longitudinal BMI measurement
lung carcinoma, longitudinal BMI measurement, chronic obstructive pulmonary disease
lung carcinoma, radon exposure measurement
lung carcinoma, squamous cell carcinoma, gastric carcinoma
metastasis measurement, colorectal cancer, survival time
metastasis measurement, metastatic colorectal cancer, disease progression measurement
non-small cell lung carcinoma
overall survival, hepatocellular carcinoma
overall survival, pancreatic carcinoma
pancreatic carcinoma
peripheral neuropathy, response to docetaxel, metastatic prostate cancer
progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B
prostate carcinoma
rectum cancer, overall survival
response to gemcitabine, pancreatic carcinoma
response to interferon, hepatocellular carcinoma, virologic response measurement
response to irinotecan, non-small cell lung carcinoma
response to platinum based chemotherapy, non-small cell lung carcinoma
response to radiation, prostate carcinoma
response to radiation, prostate carcinoma, breast carcinoma
response to radiation, prostate carcinoma, erectile dysfunction
small cell lung carcinoma
smoking status measurement, lung carcinoma
squamous cell carcinoma, esophageal carcinoma
squamous cell lung carcinoma
squamous cell lung carcinoma, family history of lung cancer
survival time, non-small cell lung carcinoma
survival time, prostate carcinoma
survival time, squamous cell carcinoma, esophageal carcinoma
thyroid carcinoma
